Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia

NCT01457040 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Stem Cell Transplantation, Hematopoietic

Interventions

DRUG: TBI+CY+VP-16
DRUG: FA+TBI+CY+VP-16

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]